Delivery Order SPE2DB22D1106-SPE2DB24FEVK1
Award Date 6/5/24
Potential Completion Date 6/27/24
Potential Value $1.9K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of ZILRETTA 32 MG VIALS, a pharmaceutical product. The award, valued at $5,258.55, was made by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the U.S. Department of Defense. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025, which serves as the primary vehicle...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product ZILRETTA 32 MG VIALS, with a ceiling value of $1,402.28 and a completion date of May 29, 2024. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and is a Firm Fixed Price Delivery Order contract without a set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies globally, has a significant...
- This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, valued at $7,011.40, is for the provision of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order under Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA, valued up to $999,999,999.00 through December 31, 2025. This single-award IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of...
- This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,857.45 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
- Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation, was awarded a firm fixed price delivery order contract worth $3,505.70 by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the delivery of ZILRETTA 32 MG VIALS with a completion date of March 14, 2024. This award is not associated with any set-aside designation. The contract is part of Amerisourcebergen Drug Corp's broader indefinite delivery contract...
- This federal contract award, valued at $7,011.40, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the delivery of ZILRETTA 32 MG VIALS, a pharmaceutical product, with a completion date of May 9, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued up to $999,999,999.00 through...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $4,457.88 firm fixed-price delivery order is for the supply of 4,568,236,556 vials of the medication ZILRETTA 32 MG. The contract has a performance period extending through June 4, 2025. AmerisourceBergen holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive global...
- This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The $2,098.20 firm-fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of April 13, 2023 and was awarded on March 23, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a significant $999,999,999...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,041,099 units of the pharmaceutical product ZILRETTA 32 MG VIALS. The $3,505.70 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corporation is the prime contractor for this award, which is not associated with any set-aside designations. Additionally,...
- This federal contract award is for the delivery of ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The prime contractor is Amerisourcebergen Drug Corp, a wholly owned subsidiary of Cencora, Inc., a major pharmaceutical distribution company. The contract has a ceiling value of $2,297.76 and is a firm fixed-price delivery order with an ultimate completion date of October 18, 2021. The contract was awarded on September 24, 2021, and...
- SPE2DB22D1106Indefinite Delivery Contract
- SPE2DB22D1106-SPE2DB24FEVK1Delivery Order
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the supply of the pharmaceutical product ZILRETTA 32 MG VIALS to the Defense Logistics Agency (DLA), a defense agency. The award has a potential value of $1,943.49 and runs through June 27, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle for the company to deliver a range of pharmaceutical products and medical supplies to DLA facilities supporting the Department of Defense worldwide. This contract award does not have a set-aside designation.
Generated 9/4/24, 9:27 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.9k | 6/5/24 |